European Heart Journal-Quality of Care and Clinical Outcomes

Article	Citations
Call for emergency action to limit global temperature increases, restore biodiversity, and protect health	77
Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study	64
Quality of Care and Long-term Survival After ST-elevation Myocardial Infarction in Adults with Cancer	55
Profiling heart failure with preserved or mildly reduced ejection fraction by cluster analysis	45
Feasibility of coronary access after transcatheter aortic valve implantation (TAVI): a systematic review and meta-analysis of observational studies	36
COP27 Climate Change Conference: urgent action needed for Africa and the world	35
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations	35
Global burden of heart failure and its underlying causes in 204 countries and territories, 1990–2021	34
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term exten	32
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study	32
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines	30
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk	30
What really matters: a patient-centered instrument to evaluate health-related quality of life in cardiovascular disease	30
Mitral regurgitation management: a systematic review of clinical practice guidelines and recommendations	29
Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations	29
Sex differences in clinical profile, management, and outcomes of patients hospitalized for atrial fibrillation in the United States	27
Case-ascertainment of acute myocardial infarction hospitalizations in cancer patients: a cohort study using English linked electronic health data	25
Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease	23
Potential for optimizing management of obesity in the secondary prevention of coronary heart disease	22
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019	22
Generalizability of randomized controlled trials in heart failure with reduced ejection fraction	22
Impact of outcome definitions on cardiovascular risk prediction in a contemporary primary prevention population	22
Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?	21
Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention	21
Impact of age on outcomes after transcatheter aortic valve implantation	21

Use of rapid cardiac magnetic resonance imaging to guide chelation therapy in patients with transfusion-dependent thalassaemia in India: UMIMI study	20
Letter to the editor in response to Kobo et al. (2022)	20
Does Down syndrome influence the outcomes of congenital cardiac surgery? A systematic review and meta-analysis	19
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease	19
European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the Eur	19
Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016	18
Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied	17
Correspondence to the European Heart Journal – Quality of Care and Clinical Outcomes in response to the paper by Warming et al. (2022): Atrial fibrillation and chronic obstructive pulmonary disease: d	17
Letter to the editor in response to Kobo et al. 2022	17
Sharing the load to improve clinical outcomes in cardiogenic shock treated using venoarterial ECMO	17
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor	16
Outcomes of ST elevation myocardial infarction in patients with cancer: a nationwide study	16
The impact of atrial fibrillation on prognosis in aortic stenosis	16
Workforce affiliation in primary and secondary prevention implantable cardioverter defibrillator patients: a nationwide Danish study	16
Defining the need for cardiovascular event definitions	15
Renin–angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health reco	15
Long-term cardiovascular disease after pre-eclampsia: time to move from epidemiology to action	15
Diagnostic accuracy, clinical characteristics, and prognostic differences of patients with acute myocarditis according to inclusion criteria	15
Secundum atrial septal defect closure in adults in the UK	14
Ambulance drive-thru troponin, ready to go?	14
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes	14
Stroke outcomes in patients with new onset perioperative atrial fibrillation complicating major abdominal surgery compared with patients with new onset non-perioperative atrial fibrillation	14
Serial cardiopulmonary exercise testing in young patients after one-and-half ventricle repair and Fontan procedure: a comparative study	13
Psychiatric morbidity and work participation in patients with congenital ventricular septal defects: a case-controlled study	13
Early goal-directed management after out-of-hospital cardiac arrest: lessons from a certified cardiac arrest centre	13
Optimizing anticoagulant therapy: is pharmacist-led intervention the best	12
Reperfusion strategies on the clinical outcomes of ST-elevation myocardial infarction patients over 80 years old in China	12
Trends in atrial fibrillation-related mortality in Europe, 2008–2019	12
Impact of the admitting ward on care quality and outcomes in non-ST-segment elevation myocardial infarction: insights from a national registry	11
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis	11
Quality indicators for improved cardiovascular care: learnings from the National Institute for Health and Care Excellence	11
Impact of cancer diagnosis on distribution and trends of cardiovascular hospitalizations in the USA between 2004 and 2017	11
The first International Consortium for Health Outcomes Measurement (ICHOM) standard dataset for reporting outcomes in heart valve disease: moving from device- to patient- centered outcomes	11
Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Re	11
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019	11
Comparison of mitral valve repair vs. replacement for mitral valve regurgitation	11
Atrial fibrillation screening and clinical outcomes: a meta-analysis of randomized controlled trials	10
Association of autoimmune diseases with cardiomyopathy: a nationwide follow-up study from Sweden	10
Cardiac rehabilitation for patients with heart failure: association with readmission and mortality risk	10
Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)	10
A hidden problem: peripheral artery disease in women	9
Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings	9
Trends and risk factors analysis of aortic aneurysm mortality in China over thirty years: based on the global burden of disease 2019 data	9
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings	9
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus	9
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events	8
Regional disparities in heart transplant mortality in the USA	8
Temporal trends in major cardiovascular events following first-time myocardial infarction in the reperfusion era – a Danish nationwide cohort study from 2000 to 2017	8
Transcatheter aortic valve replacement in mixed aortic valve disease: a systematic review and meta-analysis	8
Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study	8

Reducing the risks of nuclear war: the role of health professionals	8
Machine-learning versus traditional approaches for atherosclerotic cardiovascular risk prognostication in primary prevention cohorts: a systematic review and meta-analysis	8
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study	8
Corrigendum to: Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF Gene	8
Economic burden of cardiovascular disease in the United Kingdom (UK)	8
The utility of implantable loop recorders in patient management: an age- and indication-stratified study in the outpatient-implant era	8
Real-world management and outcomes of 7 million patients with acute coronary syndrome according to clinical research trial enrolment status: a propensity matched analysis	7
Ten-year trends in mortality and complications following catheter ablation of atrial fibrillation	7
Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation	7
Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study	7
Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United Kingdom	7
Outcomes after coronary artery bypass grafting and percutaneous coronary intervention in diabetic and non-diabetic patients	7
Left ventricular thrombus in ischaemic heart disease: diagnosis, treatment, and gaps of knowledge	7
Transition to adult care of young people with congenital heart disease: impact of a service on knowledge and self-care skills and correlates of a successful transition	7
Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI	7
Integrating patient-reported outcome measures in congenital heart disease care	7
Quality of life and the assessment of surgical quality	7
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study	7
The association of temporal sequence in atrial fibrillation and chronic obstructive pulmonary disease diagnosis and mortality risk: Reply	7
Discharge after primary percutaneous coronary intervention: the earlier the better?	7
Patient-reported vs. physician-estimated symptoms before and after transcatheter aortic valve replacement	7
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making	6
Sex-based analysis of NSTEMI processes of care and outcomes by hospital: a nationwide cohort study	6
Time waits for no one: expediting and expanding access to transcatheter aortic valve implantation	6
Long-term functional outcomes after the one-and-a-half ventricle repair: still a good option for selected patients	6
Diverticular disease and risk of incident major adverse cardiovascular events: a nationwide matched cohort study	6
Future burden of myocardial infarction in Australia: impact on health outcomes between 2019 and 2038	6
Cohort profile: the European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart)—acute coronary syndrome and percutaneous coronary intervention	6
Influence of multiple risk factor control level on cardiovascular outcomes in hypertensive patients	6
Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy	6
Women with acute and chronic myocardial ischaemia have worse early results after PTCA and CABG, but better 1-year results	6
Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence	6
Delineation of acute coronary syndromes: the acute total occlusion vs. ST-segment paradigm	6
Management of acute myocarditis: a systematic review of clinical practice guidelines and recommendations	6
Cost-effectiveness of population screening for aortic stenosis	6
Comprehensive risk factor management for hypertensive patients	5
Assessing the health impact of low seafood omega-3 intake on ischaemic heart disease: trends, demographic disparities, and forecasts	5
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic	5
Characteristics, use of guideline-recommended medical therapies and clinical outcomes of patients with heart failure not enrolled in a quality registry: A comparison with the Swedish Heart Failure Reg	5
Alerting trends in epidemiology for calcific aortic valve disease, 1990–2019: An age–period–cohort analysis for the Global Burden of Disease Study 2019	5
An early accumulation of serum uric acid confers more risk of heart failure: a 10-year prospective cohort study	5
Refined staging classification of cardiac damage associated with aortic stenosis and outcomes after transcatheter aortic valve implantation	5
Rigour of development of European Society of Cardiology, American College of Cardiology and American Heart Association guidelines over a 12-year period (2013–2024): a systematic review of guidelines	5
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis)	5
Coronary revascularization and sex differences in cardiovascular mortality after myocardial infarction in 12 high and middle-income European countries	5
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings	5
Health-related quality-of-life up to one year after myocardial infarction with non-obstructive coronary arteries	5
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary	5
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: let's talk about sex	5
Bariatric surgery and cardiovascular outcomes in patients with obesity, metabolic dysfunction-associated steatotic liver disease, and coronary artery disease: a population-based matched cohort study	5
Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry	4
Surgical management of atrial fibrillation in patients undergoing cardiac surgery: a systematic review of clinical practice guidelines and recommendations	4
The controversy between atrial fibrillation subtypes and worsening heart failure	4
Greenness exposure and mortality risk in a cardio-oncologic population	4
Vaccines and myocardial injury in patients hospitalized for COVID-19 infection: the CardioCOVID-Gemelli study	4
The beginning of wisdom is the definition of terms: counting heart failure hospitalizations	4
Ethnic disparities in care and outcomes of non-ST-segment elevation myocardial infarction: a nationwide cohort study	4
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040	4
Global, regional, and national burden of pulmonary arterial hypertension and related heart failure from 1990 to 2021, with predictions to 2050: insights from the global burden of disease study 2021	4
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry	4
Association of cumulative health status with subsequent mortality in patients with acute heart failure	4
The burden of atrial fibrillation related to metabolic risks: different countries and territories, yet the same challenges	4
Standardised and hierarchically classified heart failure and complementary disease monitoring outcome measures: european Unified Registries for heart Care evaluation and randomised trials (EuroHeart)	4
Erratum to: Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data	4
Temporal trends of prescription rates, oral anticoagulants dose, clinical outcomes, and factors associated with non-anticoagulation in patients with incident atrial fibrillation	4
Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF)	4
The impact of lifestyle on cardiovascular risk in patients with gout: a population-based cohort study	4
Management and outcome in foreign-born vs native-born patients with myocardial infarction in Sweden	4
Heart failure with preserved ejection fraction management: a systematic review of clinical practice guidelines and recommendations	4
Left atrial appendage occlusion: a niche procedure for a niche cohort?	3
Letter regarding the paper “Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus”	3
Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)	3
Safety and efficacy of direct oral anticoagulants in patients with anaemia and atrial fibrillation: an observational nationwide Danish cohort study	3
Letter to the editor in response to Sengupta et al. (2022)	3
Impact of low physical activity on cardiovascular disease across regions and demographic groups: insights from the Global Burden of Disease Study	3
Impact of intravascular ultrasound for coronary bifurcations treated with last-generation stents: insights from the ULTRA-BIFURCAT registry	3
Prognostic Impact of Anemia in Patients Undergoing Aortic Valve Replacement: A Nationwide Study	3
Relationship between hospital mortality and readmission rates after transcatheter aortic valve replacement	3
Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice	3
Targeted atrial fibrillation detection in COVID-19 vaccination clinics	3

Risk-standardized mortality metric to monitor hospital performance for chest pain presentations	3
Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	3
Cost-effectiveness of a novel AI technology to quantify coronary inflammation and cardiovascular risk in patients undergoing routine coronary computed tomography angiography	3
The state of adult congenital heart disease training from the trainee perspective: a call for action	3
Burden of cardiovascular disease attributable to metabolic risks in 204 countries and territories from 1990 to 2021	3
Contemporary trends in incident ischaemic stroke, intracranial haemorrhage, and mortality in individuals with atrial fibrillation	3
Quality of care and risk of incident atrial fibrillation in patients with newly diagnosed heart failure: a nationwide cohort study	3
Rapid Assessment and Treatment In Decompensated Aortic Stenosis (ASTRID-AS study)- A pilot study	3
Predicting new-onset heart failure hospitalization of patients with atrial fibrillation: development and external validations of a risk score	3
Urinary sodium: worth its salt?	3
Performance of the ARC-HBR criteria in ST-elevation myocardial infarction. Significance of smoking as an additional bleeding risk factor	3
Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22	3
Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study	3
Atrial fibrillation and chronic obstructive pulmonary disease: diagnostic sequence and mortality risk	2
β-blocker adherence among patients with congenital long QT syndrome: a nationwide study	2
Outcomes with intracoronary vs. intravenous epinephrine in cardiac arrest	2
Letter to the Editor in Response to Sengupta et al. (2022)	2
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology	2
Cancer and the risk of perioperative arterial ischaemic events	2
Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019	2
Mortality and morbidity after transcatheter aortic valve implantation compared to an age- and sex-matched control population: a population-based study from the SWEDEHEART registry	2
Educational attainment of children with congenital heart disease in the United Kingdom	2
Cost-effectiveness ofCYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromes	2
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrilla	2
Acute coronary occlusion with vs. without ST elevation: impact on procedural outcomes and long-term all-cause mortality	2
Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease?	2
Association of cancer with the risk of developing hypertension	2
The cost implications of a polypill for primary prevention in the TIPS-3 trial	2
The burden and trends of heart failure caused by ischaemic heart disease at the global, regional, and national levels from 1990 to 2021	2
The patient journey in chronic coronary syndromes with/without obstructive coronary arteries	2
Global representation of heart failure clinical trial leaders, collaborators, and enrolled participants: a bibliometric review 2000–20	2
Socioeconomic status and cardiovascular mortality in over 170 000 cancer survivors	2
Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort	2
Impact of pre-existing vascular disease on clinical outcomes	2
The influence of socio-demographic and clinical factors on sick leave and return to work after open-heart surgery: a nationwide registry-based cohort study	2
The impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review	2
Identification of recurrent atrial fibrillation using natural language processing applied to electronic health records	2
Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	2
Bilateral internal thoracic artery coronary grafting: risks and benefits in elderly patients	2
Health care utilization and the associated costs attributable to cardiovascular disease in Ireland: a cross-sectional study	2
Behavioural digital biomarkers enable real-time monitoring of patient-reported outcomes: a substudy of the multicentre, prospective observational SafeHeart study	2
Machine learning for prediction of all-cause mortality after transcatheter aortic valve implantation	2